A novel disease-causing mutation in AVPR2: Q96H
- PMID: 25949277
- PMCID: PMC4421472
- DOI: 10.1093/ndtplus/sfn163
A novel disease-causing mutation in AVPR2: Q96H
Abstract
A 4-month-old male infant was diagnosed with nephrogenic diabetes insipidus (NDI). Genetic testing of the arginine vasopressin receptor-2 (AVPR2) yielded a novel X-linked mutation, termed Q96H, in both the propositus and his mother; there was no family history. Protein sequence comparison between AVPR subtypes shows that Q96 is part of a highly conserved motif. Many other disease-causing mutations, confirmed with in vitro expression studies, map to surrounding residues. Molecular modelling studies showed that the equivalent residue in AVPR1 is likely critical for vasopressin binding. We posit that Q96 must be important for the integrity of AVPR2 function.
Keywords: AVPR2; DDAVP; nephrogenic diabetes insipidus; vasopressin.
Figures


Similar articles
-
Identification and characterization of a novel X-linked AVPR2 mutation causing partial nephrogenic diabetes insipidus: a case report and review of the literature.Metabolism. 2012 Jul;61(7):922-30. doi: 10.1016/j.metabol.2012.01.005. Epub 2012 Mar 3. Metabolism. 2012. PMID: 22386940 Review.
-
AVPR2 variants and V2 vasopressin receptor function in nephrogenic diabetes insipidus.Kidney Int. 1998 Dec;54(6):1909-22. doi: 10.1046/j.1523-1755.1998.00214.x. Kidney Int. 1998. PMID: 9853256
-
Functional characterization of novel loss-of-function mutations in the vasopressin type 2 receptor gene causing nephrogenic diabetes insipidus.Nephrol Dial Transplant. 2012 Apr;27(4):1521-8. doi: 10.1093/ndt/gfr487. Epub 2011 Sep 13. Nephrol Dial Transplant. 2012. PMID: 21917732
-
A novel mutation of the arginine vasopressin receptor 2 gene in a patient with congenital nephrogenic diabetes insipidus.Clin Pediatr Endocrinol. 2005;14(1):27-33. doi: 10.1297/cpe.14.27. Epub 2005 Feb 14. Clin Pediatr Endocrinol. 2005. PMID: 24790307 Free PMC article.
-
AVPR2 variants and mutations in nephrogenic diabetes insipidus: review and missense mutation significance.J Cell Physiol. 2008 Dec;217(3):605-17. doi: 10.1002/jcp.21552. J Cell Physiol. 2008. PMID: 18726898 Review.
Cited by
-
Signaling Modification by GPCR Heteromer and Its Implication on X-Linked Nephrogenic Diabetes Insipidus.PLoS One. 2016 Sep 20;11(9):e0163086. doi: 10.1371/journal.pone.0163086. eCollection 2016. PLoS One. 2016. PMID: 27649563 Free PMC article.
References
-
- Majzoub JA, Srivatsa A. Diabetes insipidus: clinical and basic aspects. Pediatr Endocrinol Rev. 2006;4(Suppl 1):60–65. - PubMed
-
- Knoers N, Monnens LA. Nephrogenic diabetes insipidus: clinical symptoms, pathogenesis, genetics and treatment. Pediatr Nephrol (Berlin, Germany) 1992;6:476–482. - PubMed
-
- Bichet DG. Vasopressin receptor mutations in nephrogenic diabetes insipidus. Semin Nephrol. 2008;28:245–251. - PubMed
-
- Arthus MF, Lonergan M, Crumley MJ, et al. Report of 33 novel AVPR2 mutations and analysis of 117 families with X-linked nephrogenic diabetes insipidus. J Am Soc Nephrol. 2000;11:1044–1054. - PubMed
-
- Wildin RS, Cogdell DE, Valadez V. AVPR2 variants and V2 vasopressin receptor function in nephrogenic diabetes insipidus. Kidney Int. 1998;54:1909–1922. - PubMed
LinkOut - more resources
Full Text Sources